Evidence map›Paper›PMID 38881370›Full record

Trial reportClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program.

Martin Unverdorben, Paolo Colonna, James Jin, Sabine Köhler, Amparo Santamaria, Manish Saxena, Amanda Borrow, Cathy Chen, Christian von Heymann, Thomas Vanassche

Abstract readMulticenter StudyClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Martin UnverdorbenGlobal Specialty Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA.
Paolo ColonnaDepartment of Cardiology, Polyclinic of Bari - Hospital, Bari, Italy.ORCID 0000-0001-5864-2012
James JinGlobal Specialty Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA.
Sabine KöhlerSerenis GmbH, Munich, Germany.
Amparo SantamariaHematology Department, University Hospital Vinalopó y Torrevieja, Alicante, Spain.ORCID 0000-0001-7727-880X
Manish SaxenaWilliam Harvey Research Institute, NIHR Barts Cardiovascular Biomedical Research Centre, London, UK.
Amanda BorrowGlobal Specialty Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA.
Cathy ChenGlobal Specialty Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA.
Christian von HeymannDepartment of Anaesthesia & Intensive Care Medicine, Emergency Medicine, and Pain Therapy, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
Thomas VanasscheDepartment of Cardiovascular Sciences, University Hospitals (UZ) Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PyridinesThiazolesAgedAged, 80 and overAtrial FibrillationCardiac CatheterizationFactor Xa InhibitorsFemaleHumansMaleTreatment OutcomeVenous ThromboembolismedoxabanFactor Xa InhibitorsPyridinesThiazolesatrial fibrillationedoxabanperiprocedural managementtranscatheter cardiovascular proceduresvenous thromboembolism

Identifiers

PMID38881370
PMCPMC11185023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.